转化基于RNA的基因疗法,使用siRNA和miRNA传递的创新纳米载体
Jitendra Singh Chaudhary1, Dilip Kumar Chanchal2, Kuldeep Singh3
1Smt. Vidyawati College of Pharmacy, Jhansi-284128, Uttar Pradesh, India.
Current gene therapy
|April 15, 2025
概括
新型纳米载体技术通过克服提供小干扰RNA (siRNA) 和microRNA (miRNA) 的挑战来增强基于RNA的基因疗法. 这些进展提高了癌症和其他疾病的治疗效率.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 纳米医学是一种纳米医学.
背景情况:
- 使用RNA的基因疗法,包括小干扰RNA (siRNA) 和microRNA (miRNA),显示出治疗癌症和其他疾病的前景.
- 在RNA疗法中的一个主要挑战是siRNA和miRNA有效和稳定地传递到向细胞,因为载体不稳定和细胞膜吸收不良而受到阻碍.
研究的目的:
- 为微RNA和小干扰RNA输送提供当前和新兴纳米载体技术的全面概述.
- 检查这些纳米载体在基因治疗中的操作原理,设计和应用.
主要方法:
- 对RNA传递纳米载体技术现有文献的审查.
- 专注于纳米载体平台,在稳定性,控制释放和交付方面展示概念证明.
- 基于脂质的纳米粒子,聚合物系统和混合纳米载体的探索.
主要成果:
- 纳米载体技术在RNA疗法的稳定性和细胞吸收方面提供了显著的改进.
- 基于脂质的纳米粒子,聚合物系统和混合纳米载体等平台在各种应用中显示出有效性.
- 能够同时提供化疗和基因的多功能纳米载体为增强癌症治疗提供了一个有前途的战略.
结论:
- 新型纳米载体技术对于解决与基于RNA的基因疗法相关的传递挑战至关重要.
- 对纳米载体设计和功能的持续研究将为更有效的基因疾病和癌症治疗铺平道路.
相关概念视频
siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
RNA Interference
25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K
Gene Therapy
24.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
24.9K
MicroRNAs
2.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
Small interfering RNAs (siRNA)
3.4K
3.4K


